IGLL5 and IL2RA expression were also positively associated with the stage of ccRCC patients, including high tumor stage, tumor grade, T stage, and more lymph node metastases (p < 0.05, Figures 4E–K). The gene discussed is IL2RA; the disease is nonpapillary renal cell carcinoma.